Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer

The combination of docetaxel, EM, and suramin is a highly effective regimen for HRPC. Although hematologic and gastrointestinal toxicities were modest, these were easily managed medically.